Compare key investment metrics of 한미약품 and 일동제약 in real time. Both stocks belong to the 경구용 비만치료제 관련주 sector. View PER (Price-to-Earnings Ratio), PBR (Price-to-Book Ratio), dividend yield, market capitalization, and 52-week high/low side by side, with automatic highlighting of the leading stock for each metric.
Comparison at a Glance
- For dividend-focused investors, 일동제약 has the edge — dividend yield 1.2% vs 한미약품's 0.47%.
- On earnings-based valuation, 일동제약 trades at a lower PER — 14.6x vs 한미약품's 31.43x. A lower PER can suggest undervaluation, but differences in growth expectations should also be considered.
- By market capitalization, 한미약품 is larger — ₩5.4T vs 일동제약's ₩528B. Larger companies tend to be less volatile, while smaller ones may offer more growth headroom.
- 한미약품's current price of 423,000원 sits at about 41% of its 52-week range (266,500원–648,000원).
- 일동제약's current price of 16,690원 sits at about 9% of its 52-week range (13,890원–45,250원).
- This comparison is for reference only, based on publicly available market data, and does not constitute investment advice.
| Metric | 한미약품 | 일동제약 |
|---|---|---|
| Price | 423,000원 | 16,690원 |
| PER | 31.43배 | 14.6배 |
| PBR | 4.13배 | 2.12배 |
| Dividend Yield | 0.47% | 1.2% |
| Market Cap | ₩5.4T | ₩528B |
| 52-Week High | 648,000원 | 45,250원 |
| 52-Week Low | 266,500원 | 13,890원 |
As of 2026-07-06 · Source: KRX (Naver Finance) public data
Frequently Asked Questions
Which has a lower PER, 한미약품 or 일동제약?
As of 2026-07-06, 일동제약 has the lower PER — about 14.6x vs 한미약품's 31.43x. PER (Price-to-Earnings Ratio) divides a stock's price by its earnings per share; a lower PER may suggest undervaluation, but growth expectations should also be considered.
What is the dividend yield difference between 한미약품 and 일동제약?
As of 2026-07-06, 일동제약 offers the higher dividend yield — about 1.2% vs 한미약품's 0.47%. Dividend yield measures annual dividends as a percentage of the stock price and fluctuates with dividend policy and price movements.
How to compare 한미약품 and 일동제약?
PFlow's stock comparison page lets you compare key investment metrics side by side — PER, PBR, dividend yield, market cap, and 52-week high/low. Each metric automatically highlights which stock has the advantage. For deeper analysis, visit each stock's dedicated detail page.